Molecular mechanisms of dominant negative activity by nuclear hormone receptors
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Human hereditary syndromes have been divided into three major classes according to Mendelian inheritance patterns-autosomal dominant, autosomal recessive, and X-linked recessive. However, recent advances in molecular biology have shed deeper insight into the nature of some of these syndromes as specific gene mutations and the functional consequences of these mutations have been described. Often, mutations are transmitted via the germ line. However, in the development of certain tumors, somatic mutation or a somatic mutation coupled with an inherited defective allele (i.e. tumor suppressor genes such as retinoblastoma or ~53) is required. Such genetic mutations can be categorized with respect to their function-gain of function (resulting in either increased normal function or acquisition of novel function), loss of function, or dominant negative activity. The latter term refers to the ability of the product of the mutant allele to interfere directly with wild type protein function (1). Examples of each of these types of mutations exist within the nuclear hormone receptor superfamily, a class of ligand-regulatable transcription factors that includes the steroid hormone, vitamin D, retinoic acid, and thyroid hormone receptors (TRs). These receptors all contain a central DNA-binding domain with two zinc finger motifs and a carboxyterminal ligand binding domain (LBD) which is important for ligand binding as well as homoand/or heterodimerization with other nuclear proteins. Several examples of gain of function mutations have occurred due to chromosomal rearrangements within the genes encoding for retinoic acid receptor (RAR) isoforms, resulting in novel fusion proteins. In acute promyelocytic leukemia, PML-RAR fusion proteins formed between a myeloid gene product of unknown function, PML, and RARcY disrupt subnuclear organization in the nucleus, perhaps by redirecting retinoid X
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McPhaul, M. J., Marcelli, M., Zoppi, S., Wilson, C. M., Griffin, J. E., & Wilson, J. D. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116093 · Cited by 140
Cited by
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Self-citationGlucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
“, titration of limiting amounts of accessory proteins or coactivators of hGRa, and occupation of DNAtarget sequences by nontransactivating a/f3-heterodimers and/or f3/f3-homodimers (8, 21, 22).”
BackgroundDesign of polydactyl zinc-finger proteins for unique addressing within complex genomes
Liu, Q., Segal, D. J., Ghiara, J. B., & Barbas, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5525 · Cited by 288
Kaneshige, M., Kaneshige, K., Zhu, X.-G., Dace, A., Garrett, L., Carter, T. A., Kazlauskaite, R., Pankratz, D. G., Wynshaw-Boris, A., Refetoff, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230285997 · Cited by 268
Yu, L., Deng, J., Shi, X., Liu, C., Yu, K., & Zhou, B. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2009.10.022 · Cited by 252
Metadata
- Authors
- Yen, P. M.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1994-11-01
- Volume
- 8
- Issue
- 11
- Pages
- 1450-1454
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W1979655333
- Cited by
- 114
- References
- 1
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.